Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pollock

Showing results (871-880 of 896) with videos related to

Pageof 90
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2020
Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surfaceUddhav K Shigdel, Seung-Joo Lee, Mathew E Sowa, et al.
Current Biology : CB|September 7, 2021
Overfishing drives over one-third of all sharks and rays toward a global extinction crisisNicholas K Dulvy, Nathan Pacoureau, Cassandra L Rigby, et al.
Eclinicalmedicine|January 23, 2023
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2Alex J Szubert, Katrina M Pollock, Hannah M Cheeseman, et al.
Journal of Medicinal Chemistry|November 24, 2025
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9Katrina L Jackson, Ning Yin, Roman V Agafonov, et al.
Ebiomedicine|November 29, 2025
Early lymph node T follicular helper cell signalling hub drives influenza vaccine response in an ancestrally diverse cohortJacqueline H Y Siu, Sofia Coelho, Aime Palomeras, et al.
Cancer Research|October 28, 2025
CFT1946 is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader that Overcomes BRAF Inhibitor ResistanceBridget T Kreger, Yanke Liang, Nicole M Reilly, et al.
Hypertension (Dallas, Tex. : 1979)|November 30, 2022
Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension - 2021 NHLBI Workshop ReportMichelle L Gumz, Daichi Shimbo, Marwah Abdalla, et al.
Eclinicalmedicine|January 19, 2022
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trialKatrina M Pollock, Hannah M Cheeseman, Alexander J Szubert, et al.
Lancet (London, England)|July 24, 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M Folegatti, Katie J Ewer, Parvinder K Aley, et al.
Nature Genetics|April 22, 2003
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasiaPamela M Pollock, Karine Cohen-Solal, Raman Sood, et al.
Pageof 90

Showing results (871-880 of 896) with videos related to

Sort By:
Pageof 90
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2020
Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surfaceUddhav K Shigdel, Seung-Joo Lee, Mathew E Sowa, et al.
Current Biology : CB|September 7, 2021
Overfishing drives over one-third of all sharks and rays toward a global extinction crisisNicholas K Dulvy, Nathan Pacoureau, Cassandra L Rigby, et al.
Eclinicalmedicine|January 23, 2023
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2Alex J Szubert, Katrina M Pollock, Hannah M Cheeseman, et al.
Journal of Medicinal Chemistry|November 24, 2025
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9Katrina L Jackson, Ning Yin, Roman V Agafonov, et al.
Ebiomedicine|November 29, 2025
Early lymph node T follicular helper cell signalling hub drives influenza vaccine response in an ancestrally diverse cohortJacqueline H Y Siu, Sofia Coelho, Aime Palomeras, et al.
Cancer Research|October 28, 2025
CFT1946 is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader that Overcomes BRAF Inhibitor ResistanceBridget T Kreger, Yanke Liang, Nicole M Reilly, et al.
Hypertension (Dallas, Tex. : 1979)|November 30, 2022
Toward Precision Medicine: Circadian Rhythm of Blood Pressure and Chronotherapy for Hypertension - 2021 NHLBI Workshop ReportMichelle L Gumz, Daichi Shimbo, Marwah Abdalla, et al.
Eclinicalmedicine|January 19, 2022
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trialKatrina M Pollock, Hannah M Cheeseman, Alexander J Szubert, et al.
Lancet (London, England)|July 24, 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M Folegatti, Katie J Ewer, Parvinder K Aley, et al.
Nature Genetics|April 22, 2003
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasiaPamela M Pollock, Karine Cohen-Solal, Raman Sood, et al.
Pageof 90